ReviewInternational journal of molecular sciences2024

Targeting Interleukin-13 Receptor α2 and EphA2 in Aggressive Breast Cancer Subtypes with Special References to Chimeric Antigen Receptor T-Cell Therapy.

Dharambir Kashyap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.